Connection
Thomas Flaig to Antineoplastic Agents, Phytogenic
This is a "connection" page, showing publications Thomas Flaig has written about Antineoplastic Agents, Phytogenic.
|
|
Connection Strength |
|
 |
|
 |
|
0.330 |
|
|
|
-
Flaig TW, Gustafson DL, Su LJ, Zirrolli JA, Crighton F, Harrison GS, Pierson AS, Agarwal R, Glod? LM. A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients. Invest New Drugs. 2007 Apr; 25(2):139-46.
Score: 0.250
-
Flaig TW, Glod? M, Gustafson D, van Bokhoven A, Tao Y, Wilson S, Su LJ, Li Y, Harrison G, Agarwal R, Crawford ED, Lucia MS, Pollak M. A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer. Prostate. 2010 Jun 01; 70(8):848-55.
Score: 0.080